PNLIP and non-small cell lung carcinoma: PTL has been found to have anti-inflammatory (Wang et al., 2016), antioxidant (Farzadfar et al., 2016), and antitumor activity in a variety of cancers, including breast (Araujo et al., 2019), acute myeloid leukemia (Darwish et al., 2019), and non-small cell lung cancer (Zhang et al., 2009).